Drugs company Redx Pharma is creating more than 100 new roles in research & development on a multi- million-pound bio campus alongside the new Royal Liverpool Hospital
Redx’s "anti-infectives" arm will develop antibiotics to treat superbugs such as MRSA and C.Diffifile as well as anti-viral treatments for conditions such as flu, hepatitis C and HIV.
Redx Oncology which is developing cancer treatments was launched last year and now employs 55 people and will employ 127 by the end of next year.
Penny Winter – The UK Knack Group
